v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Grant revenue $ 0 $ 2,387 $ 0 $ 3,150
Collaboration revenue - related party 0 11,802 258 16,901
Collaboration revenue $ 0 $ 0 $ 0 $ 12
Type of Revenue [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember
Total revenues $ 0 $ 14,189 $ 258 $ 20,063
Operating expenses:        
Research and development 3,434 10,672 6,343 24,278
General and administrative 6,492 5,878 11,379 12,702
Restructuring 0 83 0 258
Total operating expenses 9,926 16,633 17,722 37,238
Loss from operations (9,926) (2,444) (17,464) (17,175)
Other income (expense):        
Interest income 377 740 713 1,604
Other income (expense), net (3) 4 (4) 5
Total other income, net 374 744 709 1,609
Net loss and comprehensive loss $ (9,552) $ (1,700) $ (16,755) $ (15,566)
Net loss per share attributable to common stockholders, basic $ (0.16) $ (0.03) $ (0.29) $ (0.28)
Net loss per share attributable to common stockholders, diluted $ (0.16) $ (0.03) $ (0.29) $ (0.28)
Weighted average common shares outstanding, basic 57,968,608 56,026,767 57,626,986 55,703,275
Weighted average common shares outstanding, diluted 57,968,608 56,026,767 57,626,986 55,703,275